Found 381 results
Mintzes B, Lexchin J, Sutherland J, Beaulieu M, Wilkes M, Durrieu G, et al. Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States. Journal of General Internal Medicine. 2013.
Puyat JH, Daw JR, Cunningham C, Law M, Wong ST, Greyson D, et al. Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis. Social Psychiatry and Psychiatric Epidemiology. 2013.
Wong ST, Wu L, Boswell B, Housden L, Lavoie J. Strategies for moving towards equity in recruitment of rural and Aboriginal research participants. Rural and Remote Health. 2013;13.
Haggerty J, Levesque JF, Hogg W, Wong ST. The strength of primary care systems. BMJ. 2013;346.
Wong ST, Farrally V. The Utilization of Nurse Practitioners and Physician Assistants: A Research Synthesis. Vancouver: Michael Smith Foundation for Health Research; 2013.
Sivananthan SN, Puyat JH, McGrail KM. Variations in self-reported practice of physicians providing clinical care to individuals with dementia: a systematic review. Journal of the American Geriatrics Society. 2013;61(8):1277-1285.
Lavergne R, McGrail KM. What, If Anything, Does Amenable Mortality Tell Us about Regional Health System Performance? Healthcare Policy. 2013;8(3):79-91.
Sutherland JM, Hellsten E, Yu K. Bundles: An opportunity to align incentives for continuing care in Canada? Health Policy. 2012.
Sivananthan SN, Peterson S, Lavergne R, Barer ML, McGrail KM. Designation, diligence and drift: understanding laboratory expenditure increases in British Columbia, 1996/97 to 2005/06. BMC Health Services Research. 2012;12.
Law M, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184(3):297-302.
McGrail K, Lewis S. Fraser Health: Healthcare Spending Quantum Analysis. Ottawa: Canadian Foundation for Healthcare Improvement; 2012.
Crump RT, Llewellyn-Thomas HA. The importance of measuring strength-of-preference scores for health care options in preference-sensitive care. Journal of Clinical Epidemiology. 2012.
Law M, Ma T, Fisher J, Sketris IS. Independent pharmacist prescribing in Canada. Canadian Pharmacists Journal. 2012;145(1):17-23.
Greyson DL, Cunningham C, Morgan SG. Information behaviour of Canadian pharmaceutical policy makers. Health Information and Libraries Journal. 2012;29(1):16-27.
McGregor MJ, Abu-Laban RB, Ronald L, McGrail KM, Andrusiek D, Baumbusch J, et al. Nursing Home Characteristics Associated with Resident Transfers to Emergency Department. Canadian Journal on Aging. 2012;33(1):38-48.
Daw JR, Mintzes B, Law M, Hanley GE, Morgan SG. Prescription drug use in pregnancy: a retrospective, population-based study in british columbia, Canada (2001-2006). Clinical Therapeutics. 2012;34(1):239-249.e2.
Morgan SG, Thomson PA, Daw JR, Friesen MK, Dijkstra A. The Public Provision of Pharmaceuticals: A Synthesis of Policies in Ten Developed Countries. Vancouver, BC: Pharmaceutical Policy Research Collaboration; 2012.
McGrail K, McKendry R, Mooney D, Poss J, Barer ML, Sivananthan S. Research Possibilities and Priorities for Home and Continuing Care Services: An Analytic Framework to Guide Discussions. Vancouver: Centre for Health Services and Policy Research; 2012.
Sutherland J, Repin N, Crump T. Reviewing the Potential Roles of Financial Incentives for Funding Healthcare in Canada. Ottawa: Canadian Foundation for Healthcare Improvement; 2012.
Law M, Kratzer J. The Road to Competitive Generic Drug Prices in Canada. CMAJ. 2012;Online first.
Daw JR, Morgan SG. Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010. Health Policy. 2012;104(1):19-26.
McGrail KM, Lilly M, McGregor MJ, Broemeling A, Salomons K, Peterson S, et al. Who Uses Assisted Living in British Columbia? An Initial Exploration. Vancouver(BC): UBC Centre for Health Services and Policy Research; 2012.
Sutherland JM, McGrail KM, Law M, Barer ML, Crump RT. British Columbia hospitals: examination and assessment of payment reform (B-CHeaPR). BMC Health Services Research. 2011;11:150.
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
Law M, Kawasumi Y, Morgan SG. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on Health Affairs. 2011;30(12):2338-2345.